Hangzhou Tigermed Consulting plans to raise up to $1.38 billion in its Hong Kong listing, which could make the Chinese clinical trial and research firm the largest healthcare transaction …
( read original story …)
The HongKong News
Hangzhou Tigermed Consulting plans to raise up to $1.38 billion in its Hong Kong listing, which could make the Chinese clinical trial and research firm the largest healthcare transaction …
( read original story …)